Is RAC up or down today?
RAC is down 0.28% today, last at 10.57. This stock moved -0.28% versus the prior close.
RAC · RAC
RAC (RAC) is trading at 10.57, down 0.28% on the session. RAC sits at the 93% mark of its 52-week range, carries a 14-day RSI of 64, and trades above its 50-day average. Over the past month it is up 0.67%.
Leading the coverage: “Racura Oncology (ASX:RAC) Advances Clinical Pipeline as HARNESS-1 Trial Progress Becomes Key Focus - kalkine.com.au” (Google News, 6d ago). RAC is +0.28% since story.
RAC trades on a trailing P/E of 29.3 and is running 2.32% ahead of the S&P 500 over the same stretch.
Analyst firms are mostly reiterating — no strong directional shift lately.
RAC is down 0.28% today, last at 10.57. This stock moved -0.28% versus the prior close.
Leading the coverage: “Racura Oncology (ASX:RAC) Advances Clinical Pipeline as HARNESS-1 Trial Progress Becomes Key Focus - kalkine.com.au” (Google News, 6d ago). RAC is +0.28% since story. Dominant story: Symphony shares surge as company enters RAC, BLDC fan and air purifier markets - Zee Business (1 source, bullish) RSI is 64 — leaning bullish Price above 50-day average — short-term uptrend Social sentiment loads separately — see the Social tab.
Analyst firms are mostly reiterating — no strong directional shift lately.
Loaded: Mar 2026 – Sep 2026 (125 days) · Drag or scroll left for earlier dates
Symphony shares surge as company enters RAC, BLDC fan and air purifier markets - Zee Business
Why Is Race Oncology (ASX:RAC) Back in the Spotlight? - Kalkine Media
Racura Oncology (ASX:RAC) Advances Clinical Pipeline as HARNESS-1 Trial Progress Becomes Key Focus - kalkine.com.au
Racura Oncology (ASX:RAC): RC220 Clinical Pipeline Progress Drives Investor Attention - kalkine.com.au
Rithm Capital (NYSE: RITM) director eyes sale of 14,520 shares - Stock Titan